{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:48Z","timestamp":1793413548752,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41591-019-0367-9","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T12:04:15Z","timestamp":1551701055000},"page":"620-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":589,"title":["Protective autophagy elicited by RAF\u2192MEK\u2192ERK inhibition suggests a treatment strategy for RAS-driven cancers"],"prefix":"10.1038","volume":"25","author":[{"given":"Conan G.","family":"Kinsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad A.","family":"Camolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie M.","family":"Boespflug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin P.","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-8114","authenticated-orcid":false,"given":"Mona","family":"Foth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia S.","family":"Schuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Seipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance D.","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Whisenant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"G. Weldon","family":"Gilcrease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney C.","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitrin M.","family":"Rehbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa E.","family":"Affolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana L.","family":"Welm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E.","family":"Welm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney L.","family":"Scaife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2812-1042","authenticated-orcid":false,"given":"Martin","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"367_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"367_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","volume":"363","author":"D Li","year":"2004","unstructured":"Li, D. et al. Pancreatic cancer. Lancet 363, 1049\u20131057 (2004).","journal-title":"Lancet"},{"key":"367_CR3","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"367_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"367_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1158\/2159-8290.CD-11-0347","volume":"2","author":"EA Collisson","year":"2012","unstructured":"Collisson, E. A. et al. A central role for RAF\u2192MEK\u2192ERK signaling in the genesis of pancreatic ductal adenocarcinoma. Cancer Discov. 2, 685\u2013693 (2012).","journal-title":"Cancer Discov."},{"key":"367_CR6","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.ejca.2014.04.024","volume":"50","author":"JR Infante","year":"2014","unstructured":"Infante, J. R. et al. A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas. Eur. J. Cancer 50, 2072\u20132081 (2014).","journal-title":"Eur. J. Cancer"},{"key":"367_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/auto.4451","volume":"3","author":"S Kimura","year":"2007","unstructured":"Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452\u2013460 (2007).","journal-title":"Autophagy"},{"key":"367_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.4161\/auto.29394","volume":"10","author":"JM Gump","year":"2014","unstructured":"Gump, J. M. & Thorburn, A. Sorting cells for basal and induced autophagic flux by quantitative ratiometric flow cytometry. Autophagy 10, 1327\u20131334 (2014).","journal-title":"Autophagy"},{"key":"367_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"367_CR10","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nchembio.1681","volume":"10","author":"B Ronan","year":"2014","unstructured":"Ronan, B. et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat. Chem. Biol. 10, 1013\u20131019 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"367_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1158\/2159-8290.CD-15-1105","volume":"6","author":"MP Patricelli","year":"2016","unstructured":"Patricelli, M. P. et al. Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. Cancer Discov. 6, 316\u2013329 (2016).","journal-title":"Cancer Discov."},{"key":"367_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","volume":"17","author":"AG Gilmartin","year":"2011","unstructured":"Gilmartin, A. G. et al. GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition. Clin. Cancer Res. 17, 989\u20131000 (2011).","journal-title":"Clin. Cancer Res."},{"key":"367_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1021\/ml300049d","volume":"3","author":"KD Rice","year":"2012","unstructured":"Rice, K. D. et al. Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973). ACS Med. Chem. Lett. 3, 416\u2013421 (2012).","journal-title":"ACS Med. Chem. Lett."},{"key":"367_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/2159-8290.CD-13-0070","volume":"3","author":"EJ Morris","year":"2013","unstructured":"Morris, E. J. et al. Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov. 3, 742\u2013750 (2013).","journal-title":"Cancer Discov."},{"key":"367_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.aad6204","volume":"351","author":"P Lito","year":"2016","unstructured":"Lito, P. et al. Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism. Science 351, 604\u2013608 (2016).","journal-title":"Science"},{"key":"367_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.molcel.2008.12.026","volume":"33","author":"B Zheng","year":"2009","unstructured":"Zheng, B. et al. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol. Cell 33, 237\u2013247 (2009).","journal-title":"Mol. Cell"},{"key":"367_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J. et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"367_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan, D. F. et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456\u2013461 (2011).","journal-title":"Science"},{"key":"367_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. & Shaw, R. J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016\u20131023 (2011).","journal-title":"Nat. Cell Biol."},{"key":"367_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440\u2013446 (2010).","journal-title":"Cancer Res."},{"key":"367_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.freeradbiomed.2015.11.008","volume":"90","author":"AT Vessoni","year":"2016","unstructured":"Vessoni, A. T. et al. Chloroquine-induced glioma cells death is associated with mitochondrial membrane potential loss, but not oxidative stress. Free Radic. Biol. Med. 90, 91\u2013100 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"367_CR22","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1038\/sj.onc.1206622","volume":"22","author":"P Boya","year":"2003","unstructured":"Boya, P. et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22, 3927\u20133936 (2003).","journal-title":"Oncogene"},{"key":"367_CR23","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1091\/mbc.e08-03-0312","volume":"19","author":"N Fujita","year":"2008","unstructured":"Fujita, N. et al. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol. Biol. Cell 19, 4651\u20134659 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"367_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/2159-8290.CD-17-0952","volume":"8","author":"A Yang","year":"2018","unstructured":"Yang, A. et al. Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms. Cancer Discov. 8, 276\u2013287 (2018).","journal-title":"Cancer Discov."},{"key":"367_CR25","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/carcin\/bgt227","volume":"34","author":"N Awasthi","year":"2013","unstructured":"Awasthi, N. et al. Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer. Carcinogenesis 34, 2361\u20132369 (2013).","journal-title":"Carcinogenesis"},{"key":"367_CR26","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-10-4563","volume":"71","author":"NP Young","year":"2011","unstructured":"Young, N. P., Crowley, D. & Jacks, T. Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis. Cancer Res. 71, 4040\u20134047 (2011).","journal-title":"Cancer Res."},{"key":"367_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy, J. M. M., Towers, C. G. & Thorburn, A. Targeting autophagy in cancer. Nat. Rev. Cancer 17, 528\u2013542 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"367_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/2159-8290.CD-14-0049","volume":"4","author":"JM Levy","year":"2014","unstructured":"Levy, J. M. et al. Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors. Cancer Discov. 4, 773\u2013780 (2014).","journal-title":"Cancer Discov."},{"key":"367_CR29","doi-asserted-by":"publisher","first-page":"e19671","DOI":"10.7554\/eLife.19671","volume":"6","author":"JM Mulcahy Levy","year":"2017","unstructured":"Mulcahy Levy, J. M. et al. Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. eLife 6, e19671 (2017).","journal-title":"eLife"},{"key":"367_CR30","doi-asserted-by":"publisher","unstructured":"Bryant, K. L. et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-019-0368-8 (2019).","DOI":"10.1038\/s41591-019-0368-8"},{"key":"367_CR31","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1172\/JCI70454","volume":"124","author":"XH Ma","year":"2014","unstructured":"Ma, X. H. et al. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J. Clin. Invest. 124, 1406\u20131417 (2014).","journal-title":"J. Clin. Invest."},{"key":"367_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1073\/pnas.1515617113","volume":"113","author":"CH Eng","year":"2016","unstructured":"Eng, C. H. et al. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc. Natl Acad. Sci USA 113, 182\u2013187 (2016).","journal-title":"Proc. Natl Acad. Sci USA"},{"key":"367_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nature12865","volume":"504","author":"MT Rosenfeldt","year":"2013","unstructured":"Rosenfeldt, M. T. et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 504, 296\u2013300 (2013).","journal-title":"Nature"},{"key":"367_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa, C. M. et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536, 479\u2013483 (2016).","journal-title":"Nature"},{"key":"367_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41586-018-0697-7","volume":"563","author":"L Poillet-Perez","year":"2018","unstructured":"Poillet-Perez, L. et al. Autophagy maintains tumour growth through circulating arginine. Nature 563, 569\u2013573 (2018).","journal-title":"Nature"},{"key":"367_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1021\/acsmedchemlett.5b00335","volume":"7","author":"A Honda","year":"2016","unstructured":"Honda, A. et al. Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo. ACS Med. Chem. Lett. 7, 72\u201376 (2016).","journal-title":"ACS Med. Chem. Lett."},{"key":"367_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molcel.2015.05.031","volume":"59","author":"DF Egan","year":"2015","unstructured":"Egan, D. F. et al. Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates. Mol. Cell 59, 285\u2013297 (2015).","journal-title":"Mol. Cell"},{"key":"367_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1200\/JCO.2012.43.5966","volume":"31","author":"KB Kim","year":"2013","unstructured":"Kim, K. B. et al. Phase II study of the MEK1\/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor. J. Clin. Oncol. 31, 482\u2013489 (2013).","journal-title":"J. Clin. Oncol."},{"key":"367_CR39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJM199609123351107","volume":"335","author":"NJ White","year":"1996","unstructured":"White, N. J. The treatment of malaria. N. Engl. J. Med. 335, 800\u2013806 (1996).","journal-title":"N. Engl. J. Med."},{"key":"367_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","volume":"42","author":"I Ben-Zvi","year":"2012","unstructured":"Ben-Zvi, I. et al. Hydroxychloroquine: from malaria to autoimmunity. Clin. Rev. Allergy Immunol. 42, 145\u2013153 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"367_CR41","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli, G. Y. et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics 32, 2866\u20132868 (2016).","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41591-025-03713-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000}},{"DOI":"10.1038\/s41591-019-0433-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0367-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0367-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0367-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T07:19:17Z","timestamp":1745565557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0367-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1038\/s41591-019-0367-9","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"18 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the label over the bottom schematic in Fig. 1a was \u201cpH > 5.0\u201d; it should have been \u201cpH < 5.0\u201d. Further, the original article misspelt the surname of Katrin P. Guillen as \u201cGullien\u201d. These errors have been corrected in the print, PDF and HTML versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41591-025-03713-8","URL":"https:\/\/doi.org\/10.1038\/s41591-025-03713-8","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.M. served on external advisory boards for Novartis (June 2017), Genentech (December 2017) and Merck (June 2018). M.M. is the recipient of research funding from Pfizer, through a grant peer-reviewed, co-funded and awarded by the Melanoma Research Alliance.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}